{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:48:04Z","timestamp":1792010884128,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.anai.2026.08.024","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:12:43Z","timestamp":1788480763000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exhalation delivery system with fluticasone in chronic rhinosinusitis by eosinophil count and asthma and allergy status"],"prefix":"10.1016","author":[{"given":"Anju T.","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithin D.","family":"Adappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K.","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg E.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Deck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboobeh","family":"Mahdavinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zara M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney J.","family":"Schlosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Sindwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary M.","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.anai.2026.08.024_bib0001","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/alr.22741","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis 2021","volume":"11","author":"Orlandi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"suppl","key":"10.1016\/j.anai.2026.08.024_bib0002","first-page":"S1","article-title":"Clinical practice guideline adult sinusitis update","volume":"173","author":"Payne","year":"2025","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.anai.2026.08.024_bib0003","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.iac.2019.12.010","article-title":"The role of allergic rhinitis in chronic rhinosinusitis","volume":"40","author":"Helman","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"issue":"8","key":"10.1016\/j.anai.2026.08.024_bib0004","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","article-title":"Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis","volume":"7","author":"Stevens","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2026.08.024_bib0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaci.2021.03.024","article-title":"Rethinking neutrophils and eosinophils in chronic rhinosinusitis","volume":"148","author":"Delemarre","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2026.08.024_bib0006","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12890-022-02138-0","article-title":"Risk factors associated with comorbid asthma in patients with chronic rhinosinusitis with nasal polyps: a cross-sectional study","volume":"22","author":"Li","year":"2022","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.anai.2026.08.024_bib0007","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12931-018-0823-y","article-title":"Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National chronic rhinosinusitis Epidemiology Study","volume":"19","author":"Philpott","year":"2018","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.anai.2026.08.024_bib0008","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaip.2018.10.014","article-title":"Clinical characteristics of patients with chronic rhinosinusitis without nasal polyps in an academic setting","volume":"7","author":"Benjamin","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2026.08.024_bib0009","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/all.70237","article-title":"Comorbid chronic rhinosinusitis and asthma: shared risk factors and treatment implications-an EAACI task force report","volume":"81","author":"Toppila-Salmi","year":"2026","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2026.08.024_bib0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jaci.2020.04.040","article-title":"Type 2 inflammation in chronic rhinosinusitis without nasal polyps: another relevant endotype","volume":"146","author":"Delemarre","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2026.08.024_bib0011","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4193\/Rhin17.255","article-title":"The global allergy and asthma European network (GALEN rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps","volume":"57","author":"Khan","year":"2019","journal-title":"Rhinology"},{"issue":"suppl S29","key":"10.1016\/j.anai.2026.08.024_bib0012","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.anai.2026.08.024_bib0013","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fphar.2019.00294","article-title":"Modulation of allergic inflammation in the nasal mucosa of allergic rhinitis sufferers with topical pharmaceutical agents","volume":"10","author":"Watts","year":"2019","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.anai.2026.08.024_bib0014","first-page":"102","article-title":"The \u2018best method\u2019 of topical nasal drug delivery: comparison of seven techniques","volume":"44","author":"Merkus","year":"2006","journal-title":"Rhinology"},{"issue":"5","key":"10.1016\/j.anai.2026.08.024_bib0015","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jaci.2004.12.1144","article-title":"Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery","volume":"115","author":"Aukema","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2026.08.024_bib0016","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.2042-7158.1985.tb05069.x","article-title":"Intranasal drug delivery by spray and drops","volume":"37","author":"Hardy","year":"1985","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"10.1016\/j.anai.2026.08.024_bib0017","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/pharmaceutics13020246","article-title":"Current perspective on nasal delivery systems for chronic rhinosinusitis","volume":"13","author":"Tai","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.anai.2026.08.024_bib0018","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2500\/aap.2019.40.4182","article-title":"A cross-sectional, population-based survey of U.S. adults with symptoms of chronic rhinosinusitis","volume":"40","author":"Palmer","year":"2019","journal-title":"Allergy Asthma Proc"},{"issue":"suppl 1","key":"10.1016\/j.anai.2026.08.024_bib0019","first-page":"S49","article-title":"Nasal spray adherence after sinus surgery: problems and predictors","volume":"41","author":"Nabi","year":"2012","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"11","key":"10.1016\/j.anai.2026.08.024_bib0020","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1017\/S0022215117002080","article-title":"Does intranasal steroid spray technique affect side effects and compliance? Results of a patient survey","volume":"131","author":"Ganesh","year":"2017","journal-title":"J Laryngol Otol"},{"issue":"3","key":"10.1016\/j.anai.2026.08.024_bib0021","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.MLG.0000199741.08517.99","article-title":"Breath actuated device improves delivery to target sites beyond the nasal valve","volume":"116","author":"Djupesland","year":"2006","journal-title":"Laryngoscope"},{"issue":"5","key":"10.1016\/j.anai.2026.08.024_bib0022","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1089\/jamp.2011.0924","article-title":"Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump","volume":"25","author":"Djupesland","year":"2012","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"1","key":"10.1016\/j.anai.2026.08.024_bib0023","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s13346-012-0108-9","article-title":"Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review","volume":"3","author":"Djupesland","year":"2013","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"10.1016\/j.anai.2026.08.024_bib0024","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/1945892418810281","article-title":"NAVIGATE I: Randomized, placebo-controlled, double-blind trial of the exhalation delivery system with fluticasone for chronic rhinosinusitis with nasal polyps","volume":"33","author":"Sindwani","year":"2019","journal-title":"Am J Rhinol Allergy"},{"issue":"1","key":"10.1016\/j.anai.2026.08.024_bib0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaci.2018.06.010","article-title":"NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis","volume":"143","author":"Leopold","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2026.08.024_bib0026","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jaip.2023.12.016","article-title":"Efficacy of EDS-FLU for chronic rhinosinusitis: two randomized controlled trials (ReOpen1 and ReOpen2)","volume":"12","author":"Palmer","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2026.08.024_bib0027","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jaip.2024.01.048","article-title":"Unblocking the treatment stalemate in chronic rhinosinusitis without nasal polyposis (CRSsNP)","volume":"12","author":"Naclerio","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"10.1016\/j.anai.2026.08.024_bib0028","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/alr.23434","article-title":"FLU efficacy in patients with chronic rhinosinusitis with or without previous sinus surgery in ReOpen1 and ReOpen2 randomized controlled trials","volume":"14","author":"Wise","year":"2024","journal-title":"Int Forum Allergy Rhinol"},{"issue":"5","key":"10.1016\/j.anai.2026.08.024_bib0029","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1749-4486.2009.01995.x","article-title":"Psychometric validity of the 22-item sinonasal Outcome Test","volume":"34","author":"Hopkins","year":"2009","journal-title":"Clin Otolaryngol"},{"issue":"5","key":"10.1016\/j.anai.2026.08.024_bib0030","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/coa.13177","article-title":"Minimal clinically important difference for the 22-item sinonasal Outcome Test in medically managed patients with chronic rhinosinusitis","volume":"43","author":"Phillips","year":"2018","journal-title":"Clin Otolaryngol"},{"issue":"7","key":"10.1016\/j.anai.2026.08.024_bib0031","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-2600(16)30031-5","article-title":"Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies","volume":"4","author":"Ortega","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.anai.2026.08.024_bib0032","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jaip.2018.08.021","article-title":"Effects of reslizumab on asthma outcomes in a subgroup of eosinophilic asthma patients with self-reported chronic rhinosinusitis with nasal polyps","volume":"7","author":"Weinstein","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2026.08.024_bib0033","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.chest.2016.03.018","article-title":"Phase 3 study of reslizumab in patients with poorly controlled asthma: effects across a broad range of eosinophil counts","volume":"150","author":"Corren","year":"2016","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.anai.2026.08.024_bib0034","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2213-2600(14)70201-2","article-title":"Benralizumab, an anti-interleukin 5 receptor \u03b1 monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study","volume":"2","author":"Castro","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.anai.2026.08.024_bib0035","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01874-2019","article-title":"Blood eosinophil count in the general population: typical values and potential confounders","volume":"55","author":"Hartl","year":"2020","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.anai.2026.08.024_bib0036","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/bjh.14488","article-title":"Guideline for the investigation and management of eosinophilia","volume":"176","author":"Butt","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anai.2026.08.024_bib0037","unstructured":"Dupixent (dupilumab). Prescribing information. Regeneron\/Sanofi; 2026. https:\/\/www.regeneron.com\/downloads\/dupixent_fpi.pdf Accessed September 15, 2026."},{"key":"10.1016\/j.anai.2026.08.024_bib0038","series-title":"Prescribing Information","year":"2026"},{"key":"10.1016\/j.anai.2026.08.024_bib0039","unstructured":"Nucala (mepolizumab). Prescribing Information. GSK; 2025. https:\/\/gskpro.com\/content\/dam\/global\/hcpportal\/en_US\/Prescribing_Information\/Nucala\/pdf\/NUCALA-PI-PIL-IFU-COMBINED.PDF Accessed September 15, 2026."},{"key":"10.1016\/j.anai.2026.08.024_bib0040","unstructured":"Tezspire (tezepelumab-ekko). Prescribing Information. Amgen Inc and Astra Zeneca plc; 2025. http:\/\/www.azpicentral.com\/pi.html?product=tezspire Accessed September 15, 2026."},{"issue":"10","key":"10.1016\/j.anai.2026.08.024_bib0041","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/alr.22851","article-title":"Multidisciplinary consensus on a stepwise treatment algorithm for management of chronic rhinosinusitis with nasal polyps","volume":"11","author":"Han","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.anai.2026.08.024_bib0042","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/medicina55040095","article-title":"Inflammation and endotyping in chronic rhinosinusitis-a paradigm shift","volume":"55","author":"Ahern","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.anai.2026.08.024_bib0043","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fendo.2018.00235","article-title":"Regulatory and mechanistic actions of glucocorticoids on T and inflammatory cells","volume":"9","author":"Liberman","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.anai.2026.08.024_bib0044","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.anai.2021.10.014","article-title":"Yardstick for the medical management of chronic rhinosinusitis","volume":"128","author":"Borish","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2026.08.024_bib0045","first-page":"57","article-title":"Efficacy and tolerability of budesonide aqueous nasal spray in chronic rhinosinusitis patients","volume":"42","author":"Lund","year":"2004","journal-title":"Rhinology"},{"key":"10.1016\/j.anai.2026.08.024_bib0046","unstructured":"Xhance (fluticasone propionate). Prescribing Information. Paratek Pharmaceuticals, Inc; 2026. https:\/\/www.xhance.com\/docs\/xhance-full-prescribing-information.pdf Accessed September 15, 2026."}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626004230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626004230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:16:45Z","timestamp":1792009005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120626004230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":46,"alternative-id":["S1081120626004230"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2026.08.024","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exhalation delivery system with fluticasone in chronic rhinosinusitis by eosinophil count and asthma and allergy status","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2026.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}